Covidien casts off EU incontinence business
This article was originally published in Clinica
Covidien is set to divest its European incontinence business to an unnamed private French company. The deal, which is expected to close in the second quarter of 2008, will see the anonymous buyer rename the business Lille Healthcare - the incontinence arm is currently headquartered in Lille, France. The business was part of Covidien's medical supplies segment but is now considered non-core to Covidien's healthcare plan, a spokesperson for the company told Clinica. In fiscal 2007, sales from the European incontinence products made $109m, around 11% of the overall sales made by the medical supplies business, which generated $993m in revenue during fiscal 2007. Financial terms of the deal were not disclosed.
You may also be interested in...
Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic labeling, orphan exclusivity and counterfeit devices.
Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.